Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
Artificial intelligence is revolutionizing antibody development and represents the future of our industry. AI explores millions of variants in hours and identifies optimal candidates—but its true power emerges when combined with rigorous wet lab validation. This synergy between prediction and experimental confirmation accelerates development while ensuring production-ready results.
At ProteoGenix, our AI leverages ~10 billion sequences and continuously improves with each project. Concretely, it enables:
Our methodology follows a continuous iterative cycle.
AI proposes optimized variants, we produce and test them in the lab, and experimental results feed back into the model to refine subsequent recommendations. This loop ensures every prediction is validated against real data, continuously improving our models with each project.
Results from testing inform the next AI cycle, creating a feedback loop that accelerates development while minimizing risk.
AI alone isn’t enough. To deliver reliable results, it must be grounded in quality data, validated experimentally, and interpreted by experts who master both IA and biology. At ProteoGenix, we’ve built the infrastructure to make AI truly effective:
ProteoGenix provides advanced artificial intelligence tools specifically designed to optimize every step of antibody development:
Need a personalized consultation or a quote ? Message us and we will get back to you in less than 48 hours.